Overall rank by patents
#25,920
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 1 technology areas, active 2021–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C11D (DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL).
The verdict
Bocks holds 10 US patents across 1 technology areas, rank #25,920 of 50,000 tracked assignees.
Bocks Inc. has been granted 10 US utility patents between 2021 and 2022, placing Bocks Inc. at rank #25,920 across all assignees tracked by PlainPatent. This portfolio spans 1 distinct Cooperative Patent Classification (CPC) subclasses, averaging 1.6 claims per patent with primary concentration in C11D (DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL). As a US Corporation, Bocks Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Bocks sits between Blossom Innovations, Llc (10 patents, rank #25,916) and Boreal Genomics, Inc. (10 patents, rank #25,924) - the closest US assignees by grant volume. The composite Innovation Score of 32.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2022, with 10 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Bocks Inc.'s 1.6 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 1 subclass reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Bocks Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Blossom Innovations, LLC
10 patents
Blue Horizons Innovations, LLC
10 patents
Blue Skies Global LLC
10 patents
Bluedata Software, Inc.
10 patents
BodyMedia, Inc.
10 patents
Bond Formwork Systems, LLC
10 patents
BooginHead LLC
10 patents
Boreal Genomics, Inc.
10 patents
Bocks Inc.
10 patents
What this shows Bocks holds 10 patents at rank #25,920, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Bocks's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
33 Top 58% higher than 42% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 2 | 20.0% |
| 2022 | 8 | 80.0% |
Top 1 of 1 technology areas
Overall rank by patents
#25,920
Across all tracked assignees
32.8 out of 100
How to use this portfolio
Bocks's 10 grants land it in the top 58% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.